2006
Patient willingness to take teriparatide
Fraenkel L, Gulanski B, Wittink D. Patient willingness to take teriparatide. Patient Education And Counseling 2006, 65: 237-244. PMID: 16965888, PMCID: PMC1769517, DOI: 10.1016/j.pec.2006.08.004.Peer-Reviewed Original ResearchMeSH KeywordsAbsorptiometry, PhotonAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsChoice BehaviorConnecticutDrug Administration ScheduleFemaleFractures, BoneHealth Knowledge, Attitudes, PracticeHealth Services Needs and DemandHumansInjections, SubcutaneousMiddle AgedMultivariate AnalysisOsteoporosis, PostmenopausalPatient Acceptance of Health CarePostmenopauseRisk AssessmentSocioeconomic FactorsSurveys and QuestionnairesTeriparatideWomenConceptsDaily subcutaneous injectionsTreatment preferencesSubcutaneous injectionFuture fracturesMost womenAbsolute fracture riskTreatment of osteoporosisNovel treatment approachesConjoint analysis questionnairePostmenopausal womenAdaptive conjoint analysis questionnaireDaily injectionsPoor adherenceEfficacy advantageFracture riskPatients' willingnessClinical studiesAge 71Bone densitometryEffective treatmentNumber of subjectsTreatment approachesT-scoreOlder adultsWomen
2005
Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ, Gulanski B, Rosenheck R. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics. The Journal Of Clinical Psychiatry 2005, 66: 1463-7. PMID: 16420085, DOI: 10.4088/jcp.v66n1117.Peer-Reviewed Original ResearchConceptsAtypical antipsychoticsFPG levelsElevated FPGUndiagnosed hyperglycemiaUrban Veterans Affairs Medical CenterVeterans Affairs Medical CenterNormal FPG levelsPercentage of patientsBody mass indexPlasma glucose testRace/ethnicityFPG resultsAntipsychotic prescriptionsMore patientsMass indexFPG groupMedical CenterGlucose testAntipsychoticsGlucose metabolismPatientsComorbid diagnosesHyperglycemiaGlucose resultsSignificant differences